K. K. Kim

发表

A novel indole ethyl isothiocyanate (7Me-IEITC) with anti-proliferative and pro-apoptotic effects on platinum-resistant human ovarian cancer cells.

Rakesh K. Singh, S. Shaw, L. Brard, 2008, Gynecologic oncology.

Evaluation of the first Ergocalciferol-derived, non hypercalcemic anti-cancer agent MT19c in ovarian cancer SKOV-3 cell lines.

Richard G. Moore, K. Robison, Rakesh K. Singh, 2011, Gynecologic oncology.

Cytotoxic Properties of Adamantyl Isothiocyanate and Potential In vivo Metabolite Adamantyl‐N‐Acetylcystein in Gynecological Cancer Cells

Richard G. Moore, Ajay P. Singh, N. Vorsa, 2012, Chemical biology & drug design.

Description of the cytotoxic effect of a novel drug Abietyl-Isothiocyanate on endometrial cancer cell lines

Richard G. Moore, Michael A. Zompa, C. Seto, 2012, Investigational New Drugs.

Anti-angiogenic activity of cranberry proanthocyanidins and cytotoxic properties in ovarian cancer cells.

Richard G. Moore, Ajay P. Singh, N. Vorsa, 2011, International journal of oncology.

Analysis of serum HE4 levels in various histologic subtypes of epithelial ovarian cancer and other malignant tumors.

Richard G. Moore, R. Bast, S. Skates, 2021, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Purified cranberry proanthocyanidines (PAC-1A) cause pro-apoptotic signaling, ROS generation, cyclophosphamide retention and cytotoxicity in high-risk neuroblastoma cells.

Richard G. Moore, Ajay P. Singh, N. Vorsa, 2011, International journal of oncology.

Cranberry proanthocyanidins are cytotoxic to human cancer cells and sensitize platinum‐resistant ovarian cancer cells to paraplatin

R. Nussbaum, Ajay P. Singh, N. Vorsa, 2009, Phytotherapy Research.

Chemotherapeutic Effect of Calcidiol Derivative B3CD in a Neuroblastoma Xenograft Model

Rakesh K. Singh, L. Brard, T. Lange, 2010, Chemical biology & drug design.

Anti‐proliferative and Pro‐apoptotic Properties of 3‐Bromoacetoxy Calcidiol in High‐risk Neuroblastoma

N. Swamy, Rakesh K. Singh, L. Brard, 2007, Chemical biology & drug design.

Malignancy Assessment Using Gene Identification in Captured Cells Algorithm for the Prediction of Malignancy in Women With a Pelvic Mass

Richard G. Moore, M. Miller, David Englert, 2022, Obstetrics and gynecology.

A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix® PC1 System

Richard G. Moore, N. Ueno, J. Reuben, 2022, Cancers.

Correction: Iron(III)-Salophene: An Organometallic Compound with Selective Cytotoxic and Anti-Proliferative Properties in Platinum-Resistant Ovarian Cancer Cells

R. Strongin, Rakesh K. Singh, C. Mccourt, 2008, PLoS ONE.

Organometallic Iron(III)-Salophene Exerts Cytotoxic Properties in Neuroblastoma Cells via MAPK Activation and ROS Generation

Richard G. Moore, R. Strongin, Rakesh K. Singh, 2011, PloS one.

Tetrathiomolybdate induces doxorubicin sensitivity in resistant tumor cell lines.

Richard G. Moore, Rakesh K. Singh, L. Brard, 2011, Gynecologic oncology.

Induction of cytotoxicity, apoptosis and cell cycle arrest by 1-t-butyl carbamoyl, 7-methyl-indole-3-ethyl isothiocyanate (NB7M) in nervous system cancer cells

Rakesh K. Singh, L. Brard, T. Lange, 2009, Drug design, development and therapy.

HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression

Richard G. Moore, N. Yano, Rakesh K. Singh, 2021, The Journal of Immunology.

Iron(III)-Salophene: An Organometallic Compound with Selective Cytotoxic and Anti-Proliferative Properties in Platinum-Resistant Ovarian Cancer Cells

R. Strongin, Rakesh K. Singh, C. Mccourt, 2008, PloS one.

Tetrathiomolybdate mediates cisplatin-induced p38 signaling and EGFR degradation and enhances response to cisplatin therapy in gynecologic cancers

Richard G. Moore, N. Yano, Rakesh K. Singh, 2015, Scientific Reports.

A coumarin derivative (RKS262) inhibits cell-cycle progression, causes pro-apoptotic signaling and cytotoxicity in ovarian cancer cells

Rakesh K. Singh, L. Brard, T. Lange, 2011, Investigational New Drugs.

Apoptotic and chemotherapeutic properties of iron (III)-salophene in an ovarian cancer animal model

R. Strongin, Ajay P. Singh, Rakesh K. Singh, 2008, Drug design, development and therapy.

Oral RKS262 reduces tumor burden in a neuroblastoma xenograft animal model and mediates cytotoxicity through SAPK/JNK and ROS activation in vitro

T. Ashikaga, Rakesh K. Singh, S. Illenye, 2011, Cancer biology & therapy.

Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C

Richard G. Moore, Rakesh K. Singh, L. Brard, 2012, BMC Cancer.

PT19c, Another Nonhypercalcemic Vitamin D2 Derivative, Demonstrates Antitumor Efficacy in Epithelial Ovarian and Endometrial Cancer Models.

Richard G. Moore, J. Padbury, Ajay P. Singh, 2013, Genes & cancer.

Role of trypsin and protease-activated receptor-2 in ovarian cancer

Richard G. Moore, Rakesh K. Singh, K. K. Kim, 2020, PloS one.

Effect of a Vitamin D3 derivative (B3CD) with postulated anti-cancer activity in an ovarian cancer animal model

C. Raker, K. Robison, A. Stuckey, 2010, Investigational New Drugs.

Development of Potent Forchlorfenuron Analogs and Their Cytotoxic Effect in Cancer Cell Lines

Richard G. Moore, H. Itamochi, Rakesh K. Singh, 2020, Scientific Reports.

Development of Potent Forchlorfenuron Analogs and Their Cytotoxic Effect in Cancer Cell Lines

Richard G. Moore, H. Itamochi, Rakesh K. Singh, 2020, Scientific Reports.

Septins disruption controls tumor growth and enhances efficacy of Herceptin

Richard G. Moore, Jason R. Myers, C. Laggner, 2020, bioRxiv.

Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors In Vivo

Richard G. Moore, P. Jurutka, N. Dokholyan, 2022, Journal of medicinal chemistry.

Lipophilic aroylhydrazone chelator HNTMB and its multiple effects on ovarian cancer cells

Rakesh K. Singh, L. Brard, T. Lange, 2010, BMC Cancer.

Synthesis of Bicyclic Aryl Thiazolines with Selective Anti-Proliferative Effects on Human Cancer Cell Lines

N. Vorsa, R. Singh, L. Brard, 2008 .

Targeting vitamin D receptor (VDR)/immune checkpoint inhibitor receptor ligand PD-L1 axis for immunotherapy of ovarian cancer

Richard G. Moore, Rakesh K. Singh, K. K. Kim, 2018, Gynecologic Oncology.

Efficacy of a Non-Hypercalcemic Vitamin-D2 Derived Anti-Cancer Agent (MT19c) and Inhibition of Fatty Acid Synthesis in an Ovarian Cancer Xenograft Model

Richard G. Moore, J. Padbury, A. Brodsky, 2012, PloS one.

Novel Small Molecule MEK Inhibitor URML-3881 Enhances Cisplatin Sensitivity in Clear Cell Ovarian Cancer

Richard G. Moore, Rakesh K. Singh, K. K. Kim, 2019, Translational oncology.

Supporting Information S1

Richard G. Moore, J. Padbury, A. Brodsky, 2012 .

Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1

Richard G. Moore, P. Jurutka, N. Dokholyan, 2023, Cancers.

HE4 suppresses the expression of osteopontin in mononuclear cells and compromises their cytotoxicity against ovarian cancer cells

N. Yano, P. DiSilvestro, R. Singh, 2018, Clinical and experimental immunology.

Evaluation of the first Ergocalciferol-derived, non hypercalcemic anti-cancer agent MT19c in ovarian cancer SKOV-3 cell lines.

Richard G. Moore, K. Robison, Rakesh K. Singh, 2011, Gynecologic oncology.

Integrated genomics of ovarian xenograft tumor progression and chemotherapy response

Benjamin J. Raphael, Anna M. Ritz, Daniel H. Miller, 2011, BMC Cancer.

Isothiocyanate NB7M causes selective cytotoxicity, pro-apoptotic signalling and cell-cycle regression in ovarian cancer cells

Ajay P. Singh, N. Vorsa, Rakesh K. Singh, 2008, British Journal of Cancer.

Anti-angiogenic activity of cranberry proanthocyanidins and cytotoxic properties in ovarian cancer cells.

Richard G. Moore, Ajay P. Singh, N. Vorsa, 2011, International journal of oncology.